Additionally, MST1 and MST4 have been implicated in prostate cancer, whereby MST1 protein levels declined with disease progression [39] and MST4 expression has been correlated with tumourigenicity of human prostate cancer cell lines [36]. Here, STK26 is linked to prostate carcinoma.